| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/25/2013 | WO2013020870A4 Cardiovascular disease |
| 04/25/2013 | WO2013019982A3 Biosensing system with extended lifetime via cofactor recycling |
| 04/25/2013 | WO2013016449A3 Assays for the detection of microbes |
| 04/25/2013 | WO2013016379A4 Reagents for electrochemical test strips |
| 04/25/2013 | WO2013012396A9 A method and apparatus for analyzing interactions of molecules |
| 04/25/2013 | WO2013009146A3 Marker for diagnosing diabetic retinopathy |
| 04/25/2013 | WO2012170880A3 Methods and apparatus for improving in vitro measurements using boyden chambers |
| 04/25/2013 | WO2012170478A3 Methods and kits for detecting adenomas, colorectal cancer, and uses thereof |
| 04/25/2013 | WO2012166742A3 Systems and methods for genetic and biological analysis |
| 04/25/2013 | WO2012142334A3 Resolving genome fractions using polymorphism counts |
| 04/25/2013 | WO2012138470A3 Optimized oligonucleotides and methods of using same for the detection, isolation, amplification, quantitation, monitoring, screening, and sequencing of group b streptococcus |
| 04/25/2013 | WO2012120377A9 Molecular biomarker set for early detection of ovarian cancer |
| 04/25/2013 | WO2012044987A8 Genetic modifiers of cystic fibrosis |
| 04/25/2013 | WO2012016216A3 Assays for detection of glycosaminoglycans |
| 04/25/2013 | WO2011142827A3 Diagnostic markers for neuropsychiatric disease |
| 04/25/2013 | US20130104263 Endophytes and related methods |
| 04/25/2013 | US20130102837 Embryo quality assessment based on blastomere division and movement |
| 04/25/2013 | US20130102769 Interfering rna molecules |
| 04/25/2013 | US20130102757 Methods for selective targeting |
| 04/25/2013 | US20130102692 Methods for assessing risk of alzheimer's disease in a patient |
| 04/25/2013 | US20130102655 Alkynyl-derivatized cap analogs, preparation and uses thereof |
| 04/25/2013 | US20130102653 Gna11 and gnaq exon 4 mutations in melanoma |
| 04/25/2013 | US20130102582 Compositions and methods for treating and preventing coronary heart disease |
| 04/25/2013 | US20130102544 Disease-Associated Proteins |
| 04/25/2013 | US20130102499 Method for determination of activity of mitochondrial dna polymerase of falciparum malaria, and method for screening for anti-malaria compound |
| 04/25/2013 | US20130102498 Compositions and methods for detecting amyloid-beta-degrading enzyme activity |
| 04/25/2013 | US20130102497 Assay for drug discovery based on in vitro differentiated cells |
| 04/25/2013 | US20130102496 Antigen screening system |
| 04/25/2013 | US20130102495 Sperm-Specific Cation Channel, Catsper1 and Uses Therefor |
| 04/25/2013 | US20130102493 Gene expression analyses for characterizing and identifying genotoxic compounds |
| 04/25/2013 | US20130102492 Gene expression markers for colorectal cancer prognosis |
| 04/25/2013 | US20130102491 Method for the diagnosis of tuberculosis |
| 04/25/2013 | US20130102490 Method for counting chromatid copy numbers in a single cell |
| 04/25/2013 | US20130102488 Methods of Detecting Cervical Cancer |
| 04/25/2013 | US20130102487 Plasma micrornas for the detection of early colorectal cancer |
| 04/25/2013 | US20130102486 Perp as a prognostic and diagnostic marker for dysplasia and cancer |
| 04/25/2013 | US20130102485 Method of Determining a Diseased State in a Subject |
| 04/25/2013 | US20130102484 Method for the detection of gene transcripts in blood and uses thereof |
| 04/25/2013 | US20130102483 Methods for the analysis of breast cancer disorders |
| 04/25/2013 | US20130102482 Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer |
| 04/25/2013 | US20130102477 Biomarkers for non-hodgkin lymphomas and uses thereof |
| 04/25/2013 | US20130102476 Combined cgh & allele specific hybridisation method |
| 04/25/2013 | US20130102065 Small Volume and Fast Acting Optical Analyte Sensor |
| 04/25/2013 | US20130102064 Rt-pcr chip with optical detection |
| 04/25/2013 | US20130102050 Enzymatic nucleic acid synthesis: compositions and methods for inhibiting pyrophosphorolysis |
| 04/25/2013 | US20130102026 Culture medium and a method for detection of parasites |
| 04/25/2013 | US20130102025 Methods and compositions for identifying a cell phenotype |
| 04/25/2013 | US20130102024 Optical fluorescence dual sensors and methods of preparing and using them |
| 04/25/2013 | US20130102020 Detection and Characterization of Protein Interactions, Protein Interaction Modulation and Protein Interaction Modulators |
| 04/25/2013 | US20130102019 Assessing the risk of a major adverse cardiac event in patients with chest pain |
| 04/25/2013 | US20130102017 Fluorescent carbapenems |
| 04/25/2013 | US20130102016 Glucose Dehydrogenase |
| 04/25/2013 | US20130102014 Fluorinated resorufin compounds and their application |
| 04/25/2013 | US20130102009 Sirtuin activators and activation assays |
| 04/25/2013 | US20130102008 Method for Screening for S1P Lyase Inhibitors Using Cultured Cells |
| 04/25/2013 | US20130102007 Compositions and methods for characterizing and regulating olfactory sensation |
| 04/25/2013 | US20130102006 Detection method for novel ros1 fusions |
| 04/25/2013 | US20130102005 Inhibitor leaching resistant nucleic acid storage reagent |
| 04/25/2013 | US20130102004 Endometrial Phase or Endometrial Cancer Biomarkers |
| 04/25/2013 | US20130102003 Point-of-Care Immunoassay for Quantitative Small Analyte Detection |
| 04/25/2013 | US20130102000 Peptide nucleic acid probe, kit and method for detection and/or quantification of salmonella spp. and applications thereof |
| 04/25/2013 | US20130101997 Genetic marker for the diagnosis of dementia with lewy bodies |
| 04/25/2013 | US20130101994 Method of Analysing a Cell or Other Biological Material Containing a Nucleic Acid |
| 04/25/2013 | US20130101992 Diagnostic Assay For Type 1 Diabetes |
| 04/25/2013 | US20130101991 Microfluidic assay in idealized microvascular network for selection and optimization of drug delivery vehicles to simulated tumors |
| 04/25/2013 | US20130101990 Microfluidic system for amplifying and detecting polynucleotides in parallel |
| 04/25/2013 | US20130101988 Compositions, methods and kits to detect herpes simplex virus nucleic acids |
| 04/25/2013 | US20130101986 In Vitro Method for obtaining Intrahepatic Fibroblasts Infected with Hepatitis C Virus |
| 04/25/2013 | US20130101985 Methods for the detection of jc polyoma virus |
| 04/25/2013 | US20130101984 Methods of detecting sleepiness |
| 04/25/2013 | US20130101983 Non contact real time micro polymerase chain reaction system and method thereof |
| 04/25/2013 | US20130101597 Modulation of nk cell antigen specific effector activity by modulation of cxcr6 (cd186) |
| 04/25/2013 | US20130101580 Compositions and methods for prolonging lifespan |
| 04/25/2013 | US20130101560 Use of abo type |
| 04/25/2013 | US20130101558 Aav-based treatment of cholesterol-related disorders |
| 04/25/2013 | US20130101515 Method of selecting antioxidants for use in topically applied compositions |
| 04/25/2013 | US20130101513 Method of using near infrared fluorescent dyes for imaging and targeting cancers |
| 04/25/2013 | US20130101512 Crosslinked polynucleotide structure |
| 04/25/2013 | US20130098778 Concentration Determination in a Diffusion Barrier Layer |
| 04/25/2013 | US20130098777 Single, Direct Detection Of Hemoglobin A1C Percentage Using Enzyme Triggered Redox Altering Chemical Elimination (E-Trace) Immunoassay |
| 04/25/2013 | US20130098763 System and method for measuring an analyte in a sample |
| 04/25/2013 | DE102011054334B4 Verfahren zur Bestimmung der Interaktion zwischen einem Polynucleotid und Blutplättchenfaktor 4 Method for determining the interaction between a polynucleotide and platelet factor 4 |
| 04/25/2013 | DE10149786B4 Oberfläche für Untersuchungen aus Populationen von Einzelmolekülen Surface for studies of populations of single molecules |
| 04/25/2013 | CA2853088A1 Quantification of adaptive immune cell genomes in a complex mixture of cells |
| 04/25/2013 | CA2852954A1 Methods for improving inflammatory bowel disease diagnosis |
| 04/25/2013 | CA2852949A1 Compositions and methods for directional nucleic acid amplification and sequencing |
| 04/25/2013 | CA2852934A1 Method to determine zygosity of the fad3 gene in canola |
| 04/25/2013 | CA2852932A1 Method to determine zygosity of the fad2 gene in canola using end-point pcr |
| 04/25/2013 | CA2852851A1 Composite biomarker for non-invasive screening, diagnosis and prognosis of colorectal cancer |
| 04/25/2013 | CA2852812A1 Enzyme method |
| 04/25/2013 | CA2852757A1 Predictive biomarkers for breast cancer |
| 04/25/2013 | CA2852665A1 Analysis methods |
| 04/25/2013 | CA2852619A1 Modified arsenite oxidase and a biosensor for detecting arsenite |
| 04/25/2013 | CA2852481A1 Materials and methods for detecting the aryloxyalkanoate dioxygenase gene (aad-12) in plants |
| 04/25/2013 | CA2852384A1 Biomarkers useful for detection of types, grades and stages of human breast cancer |
| 04/25/2013 | CA2851913A1 Detection units and methods for detecting a target analyte |
| 04/25/2013 | CA2851752A1 Method for quantifying renal markers by urinary dosage |
| 04/25/2013 | CA2851632A1 Single, direct detection of hemoglobin a1c percentage using enzyme triggered redox altering chemical elimination (e-trace) immunoassay |
| 04/25/2013 | CA2851329A1 Epigenetic marker for the identification of il17 positive t cells in complex samples |
| 04/25/2013 | CA2850912A1 Fetal chromosomal aneuploidy diagnosis |